РОЛЬ ОБЩИХ АНЕСТЕТИКОВ В МОДУЛЯЦИИ СИСТЕМНОГО ВОСПАЛИТЕЛЬНОГО ОТВЕТА В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ
https://doi.org/10.18705/2311-4495-2017-4-5-28-36
Аннотация
Ключевые слова
Об авторах
И. А. СаввинаРоссия
д.м.н., доцент, гл. науч. сотрудник «Российского научно-исследовательского нейрохирургического института им. проф. А. Л. Поленова» филиала ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава Росси, проф. кафедры анестезиологии и реаниматологии им. В. Л. Ваневского ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И. И. Мечникова» Минздрава России;
А. А. Костарева
Россия
к.м.н., директор Института молекулярной биологии и генетики ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России;
А. В. Федоров
Россия
к.б.н., зав. НИЛ молекулярно-клеточных механизмов атеросклероза Института молекулярной биологии и генетики ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России;
Р. В. Рутковский
Россия
зав.отделением анестезиологии и реанимации с палатами интенсивной терапии № 12 ФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова » Минздрава России;
Д. А. Распутина
Россия
врач анестезиолог-реаниматолог отделения анестезиологии и реанимации с палатами интенсивной терапии № 12 ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России;
А. М. Малхозова
Россия
врач анестезиолог-реаниматолог отделения анестезиологии и реанимации с палатами интенсивной терапии № 12 ФГБУ «Национальный медицинский исследовательский центр им. В.А. Алмазова» Минздрава России;
Список литературы
1. The systemic infl ammatory response to anaesthesia and surgery. Curr Anaesth Crit Care. 2008; 19: 349–353.
2. Homburger J, Meiler S. Anesthesia drugs, immunity, and long-term outcome. Curr Opin Anaesthesiol. 2006; 19: 423–428.
3. Vallejo R, Hord E, Barna S, et al. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol. 2003; 22: 139–146.
4. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008; 22: 263–277.
5. Kelbel I, Weiss M. Anesthetics and immune function. Curr Opin Anaesthesiol. 2001; 14: 685–691.
6. Colcci D, Puig N, Hernandez P. Infl uence of anesthetic drugs on immune response: from infl ammation to immunosuppression. AO Anesthetics. 2013; 1: 21–38.
7. Schneemilch C, Schilling T, Bank U. Effects of general anesthesia on infl ammation. Best Pract Res Clin Anaesthesiol. 2004; 18: 493–507.
8. Cruz F, Rocco P, Pelosi P. Anti-infl ammatory properties of anesthetic agents. Annual Update in Intensive Care and Emergency Medicine 2017. Edited by J.-L. Vincent. Springer, 2017: 401–413.
9. Elenkov I, Chrousos G. Stress hormones, proinfl ammatory and anti-infl ammatory cytokines, and autoimmunity. Ann NY Acad Sci. 2002; 966: 290–303.
10. Kennedy B, Hall G. Neuroendocrine and infl ammatory aspects of surgery: do they affect outcome? Acta Anaesthesion Belg. 1999; 50: 205–209.
11. Graham E. The infl uence of ether and ether anestesia on bacteriolysis, agglutination and phagocytosis. J Infect Dis. 1911; 8: 147–175.
12. Simeonova G, Slovov E, Usunov R, et al. Increased apoptosis of peripheral blood mononuclear cells (PBMC) during general and epidural anaesthesia in dogs. Vet Res Commun. 2008; 32: 619–626.
13. Fridman H, Newton C, Klein T. Microbal Infection, Immunomodulation, and Drugs of Abuse. Clin Microbiol Rev. 2003; 16: 209–219.
14. Yoon-Mi L, Byeng C, Kyung-Jin Y. Impact of volatile anesthetics on oxidative stress and infl ammation. Biomed Res Int. 2015; 2015: 242709.
15. Blum F, Zuo Z. Volatile anesthetics-induced neuroinfl ammatory and anti-infl ammatory responses. Med Gas Res. 2013; 3: 16.
16. Whitaker E, Christofi F, Quinn K, et al. Selective induction of IL-1β after a brief isofl urane anesthetic in children undergoing MRI examination. J Anesth. 2017; 31: 219–224.
17. Frohlich D, Rothe G, Schwall B, et al. Thiopentone and propofol, but not methohexitone nor midazolam, inhibit neutrophil oxidative responses to the bacterial peptide FMLP. Eur J Anesthesiol. 1996; 13: 582–588.
18. Jensen A, Dahlgren C. Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro. Br J Anaesth. 1993; 70: 99–100.
19. Mikawa K, Akamatsu H, Nishina K, et al. Propofol inhibits human neutrophil function. Anest Analg. 1998; 87: 695–700.
20. Cleary T, Pickering L. Mechanisms of intralipid effect on polymorphonuclear leukocytes. J Clin Lab Immunol. 1983; 11: 21–26.
21. Pirttinkangas C, Perttila J, Salo M. Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients. Intensive Care Med. 1993; 19: 299–302.
22. Hoff G, Bauer I, Larsen B, et al. Modulation of endotoxin-stimulated TNF-alpha gene expression by ketamine and propofol in cultured human whole blood. Anaesthesist. 2001; 50: 494–499.
23. Al-Hashimi M, Scott W, Thompson J, et al. Editor’s choice: Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013; 111: 80–88.
24. Sacerdote P. Opioids and the immune system. Palliat Med. 2006; 20:s9-15.
25. Hernandez M, Flores L, Bayer B. Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther. 1993; 267: 1336–1341.
26. Hall D, Suo J, Weber R. Opioid mediated effects on the immune system: sympathetic nervous system involvement. J Neuroimmunol. 1988; 83: 29-35.
27. Bidlack J. Detection and function of opioid reception on cells from the immune system. Clin Diagn Lab Immunol. 2000; 7: 719–723.
28. Ritten H, Brack A, Machelska H, et al. Opioid peptide-expressing leukocytes: identifi cation, recruitment, and simultaneously increasing inhibition of infl ammatory pain. Anesthesiology. 2001; 95: 500–508.
29. Jacobs R, Kars M, Scheinichen D, et al. Effects of fentanyl on cellular immune functions in man. Int J Immunopharmacol. 1999; 21: 445–454.
30. Sacerdote P, Gaspani L, Rossoni G, et al. Effect of the opioid remifentanil on cellular immune response in the rat. Int J Immunopharmacol. 2001; 1: 713–719.
31. Eberhardt K, Thimm B, Spring A, et al. Dozedependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: a prospective case study. Infection. 1992; 20:12–18.
32. Chanimov M, Berman S, Weissgarten J, et al. Substances used for local and general anaesthesia in culture. Eur J Anaesthes. 2000; 17: 248–255.
33. Cavalcanti V, Santos C, Samary C, et al. Effects of short-term propofol and dexmedetomidine on pulmonary morphofunction and biological markers in experimental mild acute lung injury. Respir Physiol Neurobiol. 2014; 203:45-50.
34. Kang S, Kim Y, Hong T, et al. Effects of dexmedetomidine on infl ammatory responses in patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 2013; 57:480–487.
35. Li B, Li Y, Tian S, et al. Anti-infl ammatory effect of perioperative dexmedetomidine administered as an adjunct to general anesthesia: a meta-analysis. Sci Rep. 2015; 5: 12342.
36. Memis D, Hekimoglu S, Vatan I, et al. Effects of midazolam and dexmedetomidine on infl ammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth. 2007; 98:550-552.
37. Zavala F, Haumont J, Lenfant M. Interaction of benzodiazepines with mouse macrophages. Eur J Pharmacol. 1984; 106: 561–566.
38. Nishna K, Akamatsu H, Mikawa K, et al. The inhibitory effects of thiopental, midazolam, and ketamine on human neutrophil functions. Anesth Analg. 1998; 86: 159–165.
39. Kim S, Son S, Lee S, et al. Midazolam inhibits proinfl ammatory mediators in the lipopolysaccharideactivated macrophage. Anesthesiology. 2006; 105: 105–110.
40. Loix S, De Kock M, Henin P. The antiinfl ammation effects of ketamine: state of the art. Acta Anaesthesiol Belg. 2011; 62:47-58.
41. Welters I, Hafer G, Menzebach A, et al. Ketamine inhibits transcription factors activator protein 1 and nuclear factor-kappab, Interleukin-8 production, as well as CD11b and CD16 expression: studies in human leukocytes and leukocytic cell lines. Anesth Analg. 2010; 110:934-941.
42. Kock M, Loix S, Lavand’homme P. Ketamine and peripheral infl ammation. CNS Neurosci Ther. 2013; 19:403-410.
43. Hirota K, Lambert D. Ketamine: new uses for an old drug? Br J Anaesth. 2011; 107:123-126.
44. Hahnenkamp K, Herroeder S, Hollman M. Regional anaesthesia, local anaesthetics and the surgical stress response. Best Pract Res Clin Anaesthesiol. 2004; 18:509-527.
45. Lassen H, Henriken E, Neukirch F, et al. Treatment of tetanus; severe bone marrow depression after prolonged nitrous-oxide anaesthesia. Lancet. 1956; 270:527 –530.
46. Fellows I, Byrne A, Allison S. Adrenocortical suppression with etomidate. Lancet. 1983; 2: 54-55.
Рецензия
Для цитирования:
Саввина И.А., Костарева А.А., Федоров А.В., Рутковский Р.В., Распутина Д.А., Малхозова А.М. РОЛЬ ОБЩИХ АНЕСТЕТИКОВ В МОДУЛЯЦИИ СИСТЕМНОГО ВОСПАЛИТЕЛЬНОГО ОТВЕТА В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ. Трансляционная медицина. 2017;4(5):28-36. https://doi.org/10.18705/2311-4495-2017-4-5-28-36
For citation:
Savvina I.A., Kostareva A.A., Fedorov A.V., Rutkovskiy R.V., Rasputina D.A., Malkhozova A.M. THE ROLE OF GENERAL ANESTHETICS IN MODULATION OF THE SYSTEMIC INFLAMMATION RESPONSE DURING PERIOPERATIVE PERIOD. Translational Medicine. 2017;4(5):28-36. (In Russ.) https://doi.org/10.18705/2311-4495-2017-4-5-28-36